Personalized antibiotics for severe lung infections in the ICU
Part of Infections, Lungs & breathing clinical trials.
This trial tests a personalized approach to choosing antibiotics for people with severe lung infections in the ICU. It uses rapid tests and computer models to find the best treatment faster, which may help you recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- You are 18 years or older.
- You have a lung infection (pneumonia) that is causing sepsis (a severe body response to infection).
- You do not have COVID-19.
- You do not have a severe allergy to beta-lactam antibiotics (like penicillin).
- You are not pregnant, breastfeeding, or expected to live less than 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
This trial tests if giving antibiotics based on a patient's unique gut bacteria can prevent pneumonia in people who are on a breathing machine (ventilator) in the intensive care unit (ICU). It aims to see if this personalized approach is more effective than standard care.
Hear when a new Pulmonary Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.